About Flexible Stenting Solutions
Flexible Stenting Solutions is a Healthcare company based in Eatontown (United States) founded in 2006, and was acquired by Cordis in March 2013. Self-expanding biliary stents are developed for palliative treatment of strictures. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Flexible Stenting Solutions Inc. Its competitors include Cardiovascular Systems, AngioScore and Contego Medical; 3 of its 3 listed competitors have raised funding.
Company details
Flexible Stenting Solutions was founded in 2006 in Eatontown, United States, within the medical devices sector. Self-expanding peripheral arterial and biliary stents are developed for the palliative treatment of biliary strictures caused by malignant neoplasms. FDA clearance was obtained for the FlexStent Biliary Self-Expanding Stent System. The company was acquired by Cordis in 2013.
- Headquarters Eatontown, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website flexiblestent.com
- Social LinkedIn
- Acquired by Cordis (Mar 2013)
- Legal Name Flexible Stenting Solutions Inc
Investors in Flexible Stenting Solutions
Flexible Stenting Solutions has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cordis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cardiovascular and endovascular devices are developed and marketed by Cordis. | 1957 | cordis.com | Fremont, United States |
Investor details for Flexible Stenting Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Flexible Stenting Solutions
2 dated milestones of Flexible Stenting Solutions across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Flexible Stenting Solutions is founded.
- Exit Acquired by Cordis.
Competitors of Flexible Stenting Solutions
Flexible Stenting Solutions has 3 listed competitors in our database, 3 of them funded. They include Cardiovascular Systems, AngioScore and Contego Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| csi360.com | 1989 | Saint Paul, United States | $121.2M | 780 | Devices for treating peripheral and coronary vascular disease are developed. | |
| angioscore.com | 2003 | Fremont, United States | $87M | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | ||
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature |
Detailed competitors of Flexible Stenting Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Flexible Stenting Solutions (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Flexible Stenting Solutions
Flexible Stenting Solutions was founded in 2006.
Flexible Stenting Solutions is headquartered in Eatontown, United States. It is registered at Eatontown, New Jersey, United States.
Flexible Stenting Solutions was founded in 2006 in Eatontown, United States, within the medical devices sector. Self-expanding peripheral arterial and biliary stents are developed for the palliative treatment of biliary strictures caused by malignant neoplasms. FDA clearance was obtained for the FlexStent Biliary Self-Expanding Stent System. The company was acquired by Cordis in 2013.
Flexible Stenting Solutions's top competitors include Contego Medical, Cardiovascular Systems and AngioScore.
Flexible Stenting Solutions has 1 investor. Key investors include Cordis.
Flexible Stenting Solutions operates through Flexible Stenting Solutions Inc.
Yes. Flexible Stenting Solutions was acquired by Cordis in March 2013.
